Cargando…
Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis
To assess the humoral response to vaccination against SARS-CoV-2 in patients with rheumatoid arthritis treated with methotrexate (MTX). In total, 142 fully vaccinated individuals were included at 6 ± 1 weeks after their second vaccination [BioNTech/Pfizer (70.4%), AstraZeneca (20.4%), and Moderna (9...
Autores principales: | Feuchtenberger, Martin, Kovacs, Magdolna Szilvia, Eder, Anna, Nigg, Axel, Schäfer, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012944/ https://www.ncbi.nlm.nih.gov/pubmed/35429290 http://dx.doi.org/10.1007/s00296-022-05123-2 |
Ejemplares similares
-
Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis
por: Schäfer, Arne, et al.
Publicado: (2022) -
TNF inhibitors significantly attenuate the humoral immune response to COVID-19 vaccination in patients with rheumatoid arthritis
por: Schäfer, Arne, et al.
Publicado: (2023) -
Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis
por: Frankowski, Marek, et al.
Publicado: (2021) -
Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index
por: Castiella, Agustin, et al.
Publicado: (2023) -
Rate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions
por: Feuchtenberger, Martin, et al.
Publicado: (2016)